Nathan Slaughter

Nathan Slaughter, Chief Investment Strategist of The Daily Paycheck and High-Yield Investing, has developed a long and successful track record over the years by finding profitable investments no matter where they hide. Nathan's previous experience includes a long tenure at AXA/Equitable Advisors, one of the world's largest financial planning firms. He also honed his research skills at Morgan Keegan, where he managed millions in portfolio assets and performed consultative retirement planning services. To reach more investors, Nathan switched gears in 2004 and began writing full-time. He has since published hundreds of articles for a variety of prominent online and print publications. Nathan has interviewed industry insiders like Paul Weisbruch and CEOs like Tom Evans of Bankrate.com, and has been quoted in the Los Angeles Times for his expertise on economic moats. Nathan's educational background includes NASD Series 6, 7, 63, & 65 certifications, as well as a degree in Finance/Investment Management from Sam M. Walton School of Business, where he received a full academic scholarship. When not following the market, Nathan enjoys watching his favorite baseball team, the Cubs, and camping and fishing with his family.

Analyst Articles

During the course of 2012, investing in agricultural stocks proved to be tricky. One of the nation’s worst droughts on record up-ended the business model of so many companies as crops wilted and cattle were brought to premature slaughter.#-ad_banner-# Yet there were a few beneficiaries of the drought. Back in July, I suggested that Bunge (NYSE: BG) and Ingredion (Nasdaq: INGR) would prosper, and in that time, they’ve scored gains of 22% and 42% respectively. Back… Read More

During the course of 2012, investing in agricultural stocks proved to be tricky. One of the nation’s worst droughts on record up-ended the business model of so many companies as crops wilted and cattle were brought to premature slaughter.#-ad_banner-# Yet there were a few beneficiaries of the drought. Back in July, I suggested that Bunge (NYSE: BG) and Ingredion (Nasdaq: INGR) would prosper, and in that time, they’ve scored gains of 22% and 42% respectively. Back then, I looked at another major agricultural play, but sensed that it was too soon — perhaps the back half of 2013 and into 2014 was the time to really focus on this company, I thought. Find out why Warren Buffett buys agricultural stock, and how it’s the next big thing. He’s already loading up on shares of Archer Daniels Midland (NYSE: ADM), acquiring 6 million shares in the fourth quarter of 2012 at an average price of $27. Shares have risen a bit further since, and show signs of… Read More

The biotech industry is known for extreme innovation that can frequently lead to huge gains for early investors. Take Pfizer Inc. (NYSE: PFE) for example. When the company released its groundbreaking cholesterol medicine Lipitor in 1996, the best-selling drug in the history of the pharmaceutical industry,… Read More

My colleague David Sterman recently highlighted an interesting company called Equinix (Nasdaq: EQIX), which owns facilities that house Internet traffic equipment. That may not sound interesting by itself, but it was a rather unusual move the company recently made that caught my attention. Equinix decided to become a … Read More